Pages that link to "Q35127727"
Jump to navigation
Jump to search
The following pages link to C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge (Q35127727):
Displaying 50 items.
- Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle (Q21562299) (← links)
- Complement and its role in protection and pathogenesis of flavivirus infections (Q27490236) (← links)
- Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens. (Q30367793) (← links)
- H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. (Q30371435) (← links)
- Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades. (Q30371649) (← links)
- Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. (Q30372990) (← links)
- Prospects for developing an effective particle-mediated DNA vaccine against influenza. (Q30380300) (← links)
- Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. (Q30384878) (← links)
- A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets (Q30399675) (← links)
- Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice (Q30410129) (← links)
- Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains (Q30419472) (← links)
- Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus (Q33599086) (← links)
- Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus (Q33617793) (← links)
- CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies (Q33687979) (← links)
- Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice (Q33911897) (← links)
- Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus (Q33920103) (← links)
- Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide (Q34007255) (← links)
- C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences (Q34099087) (← links)
- Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide (Q34111798) (← links)
- Innate immunity--beginning to fulfill its promise? (Q34180985) (← links)
- Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology (Q34298878) (← links)
- Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors (Q34341426) (← links)
- The MSHA strain of Pseudomonas aeruginosa activated TLR pathway and enhanced HIV-1 DNA vaccine immunoreactivity (Q34451057) (← links)
- Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. (Q34466693) (← links)
- Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin (Q34576871) (← links)
- CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction (Q34577064) (← links)
- Genetic immunization of neonates (Q34587121) (← links)
- Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene (Q34881830) (← links)
- Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats (Q34976024) (← links)
- Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies (Q34999724) (← links)
- Protective B Cell Responses to Flu—No Fluke! (Q35158499) (← links)
- Evolution of complement as an effector system in innate and adaptive immunity. (Q35176437) (← links)
- Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins (Q35613328) (← links)
- Tumor vaccines. (Q35671699) (← links)
- Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines (Q35739123) (← links)
- Nonviral DNA vectors for immunization and therapy: design and methods for their obtention (Q35791186) (← links)
- DNA fusion gene vaccines against cancer: from the laboratory to the clinic. (Q35826392) (← links)
- Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities (Q35965224) (← links)
- Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunization (Q36066222) (← links)
- Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1. (Q36114395) (← links)
- Complement-Dependent Transport of Antigen into B Cell Follicles (Q36337689) (← links)
- Enhancement of gp120-Specific Immune Responses by Genetic Vaccination with the Human Immunodeficiency Virus Type 1 Envelope Gene Fused to the Gene Coding for Soluble CTLA4 (Q36473515) (← links)
- Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge. (Q36506905) (← links)
- Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus (Q36559914) (← links)
- Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant (Q36593900) (← links)
- Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity (Q36751636) (← links)
- Effective induction of high-titer antibodies by viral vector vaccines (Q36770379) (← links)
- Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization. (Q36782184) (← links)
- Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses (Q36827388) (← links)
- Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus (Q36960498) (← links)